Found: 15
Select item for more details and to access through your institution.
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 10, p. 1423, doi. 10.1093/cid/ciad370
- By:
- Publication type:
- Article
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1646, doi. 10.1093/cid/ciad020
- By:
- Publication type:
- Article
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. e34, doi. 10.1093/infdis/jiad580
- By:
- Publication type:
- Article
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 381, doi. 10.1111/hiv.13588
- By:
- Publication type:
- Article
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long‐acting cabotegravir and rilpivirine in clinical trials.
- Published in:
- HIV Medicine, 2023, v. 24, n. 5, p. 568, doi. 10.1111/hiv.13439
- By:
- Publication type:
- Article
1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S558, doi. 10.1093/ofid/ofz360.1396
- By:
- Publication type:
- Article
2495. Pharmacokinetics of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injectables in HIV-infected Individuals through 48 Weeks in the FLAIR and ATLAS Phase 3 Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S865, doi. 10.1093/ofid/ofz360.2173
- By:
- Publication type:
- Article
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
- Published in:
- Therapeutic Advances in Infectious Disease, 2023, v. 10, p. 1, doi. 10.1177/20499361231214626
- By:
- Publication type:
- Article
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 674, doi. 10.1002/cpdd.664
- By:
- Publication type:
- Article
A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 664, doi. 10.1002/cpdd.655
- By:
- Publication type:
- Article
Effect of a High‐Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor Cabotegravir.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 443, doi. 10.1002/cpdd.620
- By:
- Publication type:
- Article
Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 509, doi. 10.1002/cpdd.272
- By:
- Publication type:
- Article
Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4607, doi. 10.1111/bcp.15439
- By:
- Publication type:
- Article
Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 4, p. 1667, doi. 10.1111/bcp.14980
- By:
- Publication type:
- Article
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 7, p. 1499, doi. 10.1111/bcp.13236
- By:
- Publication type:
- Article